Jennifer Kimberly Lue

Statistics

Publications

Citations

1.3K

H-Index

Active since

2011

Affiliations

Columbia University Irving Medical Center(Current)

Memorial Sloan Kettering Cancer Center

Columbia University

Moffitt Cancer Center

University of Washington

Jennifer Kimberly Lue is an author at Columbia University Irving Medical Center specializing in medicine, oncology, and hematologic malignancy therapy.

ORCID

Publications per year

2011–2025

Publications

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study

Lorenzo Falchi, Helen Ma, Sandra E. Klein et al. · Blood · 2020 · 185 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +4

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission

Daniel J. Landsburg, Marissa K. Falkiewicz, Joseph Maly et al. · Journal of Clinical Oncology · 2017 · 174 citations

Medicine, Oncology, Cell Therapy +11

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma

Jennifer E. Amengual, Renee Lichtenstein, Jennifer Kimberly Lue et al. · Blood · 2017 · 134 citations · Full text

Life Sciences, Immunology, Oncology +8

Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study

Owen A. O’Connor, Lorenzo Falchi, Jennifer Kimberly Lue et al. · Blood · 2019 · 128 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +4

Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial

Owen A. O’Connor, Jennifer Kimberly Lue, Ahmed Sawas et al. · The Lancet Oncology · 2017 · 118 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 26